Skip to main content
. 2012 Jul 28;2:35. doi: 10.1186/2110-5820-2-35

Table 1.

Pharmacokinetic parameters of selected beta-lactam antibiotics in critically ill patients without renal dysfunction

Antibiotic Patients Dose Vd (l/kg) CL (ml/min) T½(h) Cmax(mg/ml) AUC (mg·h/L) MIC targeted (mg/L) PD target achieved Reference
Cefepime
12
2 g q12h
0.34*
123
3.2
 
346
4
77% T > MIC
[18]
19
2 g q8h
0.36
88.2*
3.37
68
310
32
34% T > 4xMIC
[20]
13
2 g q12h
0.32*
134
2.5
 
249
 
 
[33]
7
2 g q12h
0.47*
125
3.42
 
305
7
80% T > MIC90
[19]
5
100% T > MIC90
17
2 g q8h
0.37
88.2*
3.37
66.56
324.02
 
 
[34]
Ceftazidime
15
2 g q8h
0.81*
151
4.75
 
277.31
 
 
[21]
12
2 g q8h
0.27*
 
3.48
124.4
331
4
92% T > MIC
[35]
17
2 g q8h
0.51
63.7*
6.28
61.65
523.49
 
 
[34]
18
2 g q8h
0.48
112*
5.84
63
522
32
45% T > 4xMIC
[20]
10
2 g q8h
0.23
112*
1.98
 
 
 
 
[36]
49
2 g q8h or 6 g CI/day
0.67*
91.3
 
 
 
 
 
[22]
Meropenem
8
2 g q8h or
0.38*
156.7
2.4
110.1
193.8
 
100% T > MIC
[37]
7
2 g LD + 3 g CI/day
0.37*
128.3
 
 
117.5
 
100% T > MIC
16
1 g q8h
0.43
130.9*
2.05
35
132
8
57% T > 4xMIC
[20]
10
1 g q8h or 3 g CI/day
0.32*
226.7
 
 
 
 
 
[23]
10
1 g q8h
0.39*
191
2.13
46.6
99.5
0.25-1
100% T > MIC
[38]
Piperacillin
8
12/1.5 g PIP/TAZ CI
0.33
286.7
 
144
 
 
 
[24]
8
4/0.5 PIP/TAZ q6h or q8h
 
266.6
 
 
 
27
4 g q6h
0.38
141.4*
2.58
123
469
64
33% T > 4xMIC
[20]
Ceftriaxone
54
2 g qd
0.28*
14.7
9.6
 
 
8
16% T > MIC
[25]
10
2 g qd
0.28*
41.3
6.4
204.9
 
 
 
[30]
Ertapenem
17
1 g CI/day
0.21*
43.2
4.15
90
418
2
25% T > MIC
[39]
8
1 g qd
0.85*
200.5
5.7
94.1
317.7
 
 
[26]
Flucloxacillin 10   0.29* 150.2 2.45         [27]

Vd, volume of distribution; CL, clearance; Cmax, peak serum concentration; AUC, area under the concentration vs. time curve; MIC, minimum inhibitory concentration; CI, continuous infusion; LD, loading dose; PIP, piperacillin; TAZ, tazobactam; *Data were converted considering 70 kg body weight.